Jonathan Broxton won’t need surgery after no structural damage was found in his elbow, but the Dodgers have placed him on the disabled list with a bone spur.
Shutting him down for a while certainly makes sense even if the Dodgers are convinced there’s nothing significantly wrong with Broxton’s elbow. His velocity has been down, his walks have been up, and too many of his outings have been messy going all the way back to the middle of last season.
After four-plus seasons of dominance Broxton has a 7.02 ERA and 35/32 K/BB ratio in 42 innings since June of last year. He may not be injured, but he’s definitely hurt and there’s no reason to let him get knocked around at less than full strength any longer.
To replace Broxton on the roster and in the bullpen the Dodgers have recalled Kenley Jansen, who was optioned to Double-A just a few days ago. Jansen was a revelation as a rookie and has racked up 22 strikeouts in 13 innings this year, but shaky command led to the Dodgers (briefly) demoting him.
Steven Matz underwent season-ending surgery on his left elbow today. The procedure was to reposition a compressed nerve in his elbow.
Matz, 26, has struggled over 13 starts, posting a 6.08 ERA with a 48/19 K/BB ratio in 66.2 innings. That line was, obviously, a function of the bum nerve in the bum elbow. Trouble aside, Matz is expected to be ready for Opening Day in 2018.
Back in April the Mariners designated outfielder Leonys Martin for assignment. He cleared waivers, accepted an assignment to Triple-A Tacoma and proceeded to hit .312/.352/.506 in 84 minor league games, leading to the Mariners calling him up on July 30.
In 19 games since then he’s hit a bit better than he did back in April, but not great: .230/.266/.426. So they just designated him for assignment again. The Rainers only have six more games this season, so he’s likely not going back there. Given that he’s arbitration eligible and the M’s are unlikely to tender him a contract, he’s likely to elect free agency once he clears waivers. Which he will, because he’s making nearly $5 million this year.
Odd year for Martin, who will likely be competing for a roster spot someplace next spring.